Developing New Immunosuppression for the Next Generation of Transplant Recipients: The Path Forward

M. D. Stegall; R. E. Morris; R. R. Alloway; R. B. Mannon

doi:10.1111/ajt.13582

Developing New Immunosuppression for the Next Generation of Transplant Recipients: The Path Forward

M. D. Stegall, R. E. Morris, R. R. Alloway, R. B. Mannon

Transplant Surgery

Research output: Contribution to journal › Article › peer-review

36 Scopus citations

Abstract

The development of new immunosuppressive drugs has slowed markedly over the past several years, and the outlook that improved therapy will be available to the next generation of transplant recipients is bleak. In this viewpoint, the authors outline some of important barriers to new drug development and suggest specific steps that the transplant community can take to overcome them.

Original language	English (US)
Pages (from-to)	1094-1101
Number of pages	8
Journal	American Journal of Transplantation
Volume	16
Issue number	4
DOIs	https://doi.org/10.1111/ajt.13582
State	Published - Apr 1 2016

ASJC Scopus subject areas

Immunology and Allergy
Transplantation
Pharmacology (medical)

Access to Document

10.1111/ajt.13582

Cite this

@article{aaad9f1401774d67948b169f68bd1cb2,

title = "Developing New Immunosuppression for the Next Generation of Transplant Recipients: The Path Forward",

abstract = "The development of new immunosuppressive drugs has slowed markedly over the past several years, and the outlook that improved therapy will be available to the next generation of transplant recipients is bleak. In this viewpoint, the authors outline some of important barriers to new drug development and suggest specific steps that the transplant community can take to overcome them.",

author = "Stegall, {M. D.} and Morris, {R. E.} and Alloway, {R. R.} and Mannon, {R. B.}",

year = "2016",

month = apr,

day = "1",

doi = "10.1111/ajt.13582",

language = "English (US)",

volume = "16",

pages = "1094--1101",

journal = "American Journal of Transplantation",

issn = "1600-6135",

publisher = "Wiley-Blackwell",

number = "4",

}

TY - JOUR

T1 - Developing New Immunosuppression for the Next Generation of Transplant Recipients

T2 - The Path Forward

AU - Stegall, M. D.

AU - Morris, R. E.

AU - Alloway, R. R.

AU - Mannon, R. B.

PY - 2016/4/1

Y1 - 2016/4/1

N2 - The development of new immunosuppressive drugs has slowed markedly over the past several years, and the outlook that improved therapy will be available to the next generation of transplant recipients is bleak. In this viewpoint, the authors outline some of important barriers to new drug development and suggest specific steps that the transplant community can take to overcome them.

AB - The development of new immunosuppressive drugs has slowed markedly over the past several years, and the outlook that improved therapy will be available to the next generation of transplant recipients is bleak. In this viewpoint, the authors outline some of important barriers to new drug development and suggest specific steps that the transplant community can take to overcome them.

UR - http://www.scopus.com/inward/record.url?scp=84953247205&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84953247205&partnerID=8YFLogxK

U2 - 10.1111/ajt.13582

DO - 10.1111/ajt.13582

M3 - Article

C2 - 26730885

AN - SCOPUS:84953247205

SN - 1600-6135

VL - 16

SP - 1094

EP - 1101

JO - American Journal of Transplantation

JF - American Journal of Transplantation

IS - 4

ER -

Developing New Immunosuppression for the Next Generation of Transplant Recipients: The Path Forward

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this